Blog
RSS FeedPosted by Michael Wonder on 02 Mar 2023
Ultra-fast insulin drug Fiasp to be removed from PBS making it unaffordable for many diabetes sufferers
2 March 2023 - For the past six months, 14-year-old Freya Goldston has attended more school, swimming training and increased her ...
Posted by Michael Wonder on 02 Mar 2023
Affordable treatment for recurrent melanoma
2 March 2023 - From 1 March 2023, Australians with recurrent melanoma will have a new treatment option subsidised by the ...
Posted by Michael Wonder on 28 Feb 2023
Schedule of Pharmaceutical Benefits - 1 March 2023
1 March 2023 - The March 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 24 Feb 2023
Recommendations made out of session by the PBAC November 2022 and March 2023 meetings
24 February 2023 - Recommendations made out of session by the PBAC between its November 2022 and March 2023 meetings are ...
Posted by Michael Wonder on 20 Feb 2023
Improve ventilation and make antiviral drug widely available, long COVID inquiry hears
20 February 2023 - GPs say they are unable to properly care for the hundreds of thousands of Australians with ...
Posted by Michael Wonder on 20 Feb 2023
1.6 million cheaper medicines in January
19 February 2023 - New analysis by the Department of Health and Aged Care shows that more than 1.6 million prescriptions ...
Posted by Michael Wonder on 13 Feb 2023
Like Medicare, the PBS urgently needs overhauling – for all our sakes
10 February 2023 - Trent Zimmerman says it would be a mistake for Australia to narrow its health reform agenda ...
Posted by Michael Wonder on 12 Feb 2023
AMA calls for two months of medicines to be dispensed from a single script
12 February 2023 - The Federal Government must show leadership and implement the recommendations of the independent PBAC to increase the ...
Posted by Michael Wonder on 10 Feb 2023
Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (February 2023)
10 February 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 27 January 2023. ...
Posted by Michael Wonder on 08 Feb 2023
All adults now eligible for a 2023 COVID-19 booster dose
8 February 2023 - The Australian Government has accepted advice from the Australian Technical Advisory Group on Immunisation that all adults ...
Posted by Michael Wonder on 06 Feb 2023
Changes to HPV vaccine dose schedule for young Australians
6 February 2023 - From 6 February 2023 the human papillomavirus vaccine schedule will become a single dose schedule. ...
Posted by Michael Wonder on 03 Feb 2023
Improved access to PBS medicines for pulmonary arterial hypertension
3 February 2023 - Access to pulmonary arterial hypertension PBS medicines has further improved as an outcome of the post-market review ...
Posted by Michael Wonder on 01 Feb 2023
New Parkinson's disease treatment added to PBS
1 February 2023 - From 1 February, Australians with Parkinson’s disease will have access to a new medicine on the PBS. ...
Posted by Michael Wonder on 31 Jan 2023
Schedule of Pharmaceutical Benefits - 1 February 2023
1 February 2023 - The February 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Jan 2023
Call for Enhertu to be registered on Pharmaceutical Benefits Scheme
31 January 2023 - Sarah Lee has been forced to use her super and life insurance to pay for the treatment. ...